This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
SAN DIEGO and SEATTLE,
Oct. 14, 2013 /PRNewswire/ --
Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Atossa Genetics, Inc. (NASDAQ: ATOS) has filed a federal securities fraud class action complaint in the U.S. District Court, Western District of
Washington. The complaint alleges that the company and certain of its officers violated the Securities and Exchange Act of 1934 between
November 8, 2012 and
October 4, 2013 (the "Class Period").
Learn more about our investigation on our Shareholder Rights Blog:
http://www.robbinsarroyo.com/shareholders-rights-blog/atossa-genetics-inc/Atossa Accused of Failing to Disclose Material Adverse Facts to Investors Regarding its MASCT System and MASCT System Collection Test (collectively, the "MASCT System")
Shares of Atossa fell
$2.47 per share, or more than 46%, on
October 4, 2013, after the company announced "a voluntary recall to remove the ForeCYTE Breast Health Test and the Mammary Aspiration Specimen Cytology Test (MASCT) device from the market." This steep decline follows an initial 5.6% decline per share on
February 25, 2013, following the announcement that the company received a warning letter from the U.S. Food and Drug Administration ("FDA") regarding the MASCT System.
According to the complaint, Atossa made false and/or misleading statements, as well as failed to disclose the following material adverse facts about its business and financial condition. Atossa was:
required, but failed, to submit an additional 510(k) notification to obtain necessary FDA clearance as it made material changes to the Nipple Aspirate Fluid specimen collection process;
improperly marketing its devices by using certain promotional claims to market the ForeCYTE Breast Health Test and the MASCT device; and
was in violation of FDA Good Manufacturing Practices regulations.
If you invested in Atossa and would like to discuss your
shareholder rights please contact attorney
Darnell R. Donahue at (800) 350-6003,
DDonahue@robbinsarroyo.com, or via the
shareholder information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than
$1 billion of value for themselves and the companies in which they have invested. For more information, please go to
Attorney Advertising. Past results do not guarantee a similar outcome.